Literature DB >> 33225771

Nanocarriers-loaded with natural actives as newer therapeutic interventions for treatment of hepatocellular carcinoma.

Mahfoozur Rahman1, Waleed H Almalki2, Majed Alrobaian3, Jawed Iqbal4, Saad Alghamdi5, Khalid S Alharbi6, Nabil K Alruwaili7, Abdul Hafeez8, Adil Shaharyar9, Tanuja Singh10, Mohammad Waris10, Vikas Kumar1, Sarwar Beg11.   

Abstract

Introduction: Cancer has always been a menace for the society. Hepatocellular carcinoma (HCC) is one of the most lethal and 3rdlargest causes of deaths around the world.Area covered: The emergence of natural actives is considered as the greatest boon for fighting cancer. The natural actives take precedence over the traditional chemotherapeutic drugs in terms of their multi-target, multi-level and coordinated effects in the treatment of HCC. Literature reports have indicated the tremendous potential of bioactive natural products in inhibiting the HCC via molecular drug targeting, augmented bioavailability, and the ability for both passive or active targeting and stimulus-responsive drug release characteristics. This review provides a newer treatment approaches involved in the mechanism of action of different natural actives used for the HCC treatment via different molecular pathways. Besides, the promising advantage of natural bioactive-loaded nanocarriers in HCC treatment has also been also presented in this review. Expert opinion: The remarkable outcomes have been observed with therapeutic efficacy of the nanocarriers of natural actives in the treatment of HCC.Furthermore, it requires a thorough assessment of the safety and efficacy evaluation of the nanocarriers for the delivery of targeted natural active ingredients in HCC.].

Entities:  

Keywords:  Hepatocellular carcinoma; liposomes; nanomedicine; nanoparticles; natural actives; targeted therapy

Mesh:

Substances:

Year:  2021        PMID: 33225771     DOI: 10.1080/17425247.2021.1854223

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  2 in total

1.  Hispolon-Loaded Liquid Crystalline Nanoparticles: Development, Stability, In Vitro Delivery Profile, and Assessment of Hepatoprotective Activity in Hepatocellular Carcinoma.

Authors:  Mohammad Javed Ansari; Mahfoozur Rahman; Khalid S Alharbi; Waleed M Altowayan; Ahmed Mahmoud Abdelhaleem Ali; Waleed H Almalki; Md Abul Barkat; Tanuja Singh; Shehla Nasar; Md Habban Akhter; Sarwar Beg; Hani Choudhry
Journal:  ACS Omega       Date:  2022-03-10

Review 2.  Emerging nanobiotechnology for precise theranostics of hepatocellular carcinoma.

Authors:  Mengjiao Xu; Liu Yang; Yanjie Lin; Yao Lu; Xiaoyue Bi; Tingting Jiang; Wen Deng; Lu Zhang; Wei Yi; Yao Xie; Minghui Li
Journal:  J Nanobiotechnology       Date:  2022-09-29       Impact factor: 9.429

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.